Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production.[1] Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH.[1] In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals.[2]

References

edit
  1. ^ a b Kansteiner, Fraiser (March 31, 2021). "Nitto Denko lays out $226M to boost oligonucleotide production in a bustling RNA market". Fierce Pharma. Retrieved June 3, 2024.
  2. ^ "Nitto Denko Avecia Inc acquires businesses of Irvine Pharmaceutical Services, Avrio Biopharmaceuticals". Reuters. October 11, 2016. Retrieved June 3, 2024.
edit